BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX) Return On Equity

Annual ROE:

18.68%-31.05%(-62.44%)
December 31, 2024

Summary

  • As of today, BCRX annual return on equity is 18.68%, with the most recent change of -31.05% (-62.44%) on December 31, 2024.
  • During the last 3 years, BCRX annual ROE has fallen by -153.36% (-89.14%).
  • BCRX annual ROE is now -99.30% below its all-time high of 2673.89%, reached on December 31, 2013.

Performance

BCRX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXprofitability metrics

Quarterly ROE:

7.86%-3.57%(-31.23%)
June 30, 2025

Summary

  • As of today, BCRX quarterly return on equity is 7.86%, with the most recent change of -3.57% (-31.23%) on June 30, 2025.
  • Over the past year, BCRX quarterly ROE has dropped by -24.24% (-75.51%).
  • BCRX quarterly ROE is now -99.37% below its all-time high of 1254.11%, reached on December 31, 2013.

Performance

BCRX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

BCRX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-62.4%-75.5%
3Y3 Years-89.1%-94.1%
5Y5 Years+107.5%+100.9%

BCRX ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-89.1%at low-92.7%at low
5Y5-Year-89.1%+101.0%-98.5%+100.2%
All-TimeAll-Time-99.3%+101.0%-99.4%+100.0%

BCRX ROE History

DateAnnualQuarterly
Jun 2025
-
7.86%(-31.2%)
Mar 2025
-
11.43%(-39.0%)
Dec 2024
18.68%(-62.4%)
18.75%(-29.0%)
Sep 2024
-
26.40%(-17.8%)
Jun 2024
-
32.10%(-33.4%)
Mar 2024
-
48.19%(-15.8%)
Dec 2023
49.73%(-40.7%)
57.22%(-13.9%)
Sep 2023
-
66.46%(-14.1%)
Jun 2023
-
77.41%(-7.7%)
Mar 2023
-
83.89%(-22.4%)
Dec 2022
83.88%(-51.2%)
108.06%(+1.6%)
Sep 2022
-
106.37%(-19.9%)
Jun 2022
-
132.79%(-10.3%)
Mar 2022
-
147.98%(-12.6%)
Dec 2021
172.04%(+108.9%)
169.22%(-35.2%)
Sep 2021
-
261.14%(-49.2%)
Jun 2021
-
513.75%(+109.6%)
Mar 2021
-
-5360.22%(-678.6%)
Dec 2020
-1925.37%(-673.4%)
-688.40%(-22.1%)
Sep 2020
-
-563.87%(+34.2%)
Jun 2020
-
-856.52%(+79.3%)
Mar 2020
-
-4134.45%(-352.2%)
Dec 2019
-248.94%(-63.5%)
-914.36%(-28.8%)
Sep 2019
-
-709.93%(-105.1%)
Jun 2019
-
-346.11%(-64.3%)
Mar 2019
-
-210.65%(-30.7%)
Dec 2018
-152.26%(+1.2%)
-161.17%(-26.2%)
Sep 2018
-
-127.72%(-2.5%)
Jun 2018
-
-124.56%(+0.4%)
Mar 2018
-
-125.12%(+5.4%)
Dec 2017
-154.16%(+31.1%)
-132.31%(+12.0%)
Sep 2017
-
-150.29%(+48.0%)
Jun 2017
-
-288.95%(-5.9%)
Mar 2017
-
-272.79%(-9.6%)
Dec 2016
-223.70%(-220.7%)
-248.84%(-14.1%)
Sep 2016
-
-218.04%(-55.2%)
Jun 2016
-
-140.52%(-132.7%)
Mar 2016
-
-60.38%(-53.0%)
Dec 2015
-69.75%(+42.5%)
-39.46%(+21.5%)
Sep 2015
-
-50.27%(-27.8%)
Jun 2015
-
-39.35%(+51.8%)
Mar 2015
-
-81.57%(+12.5%)
Dec 2014
-121.30%(-104.5%)
-93.24%(+18.6%)
Sep 2014
-
-114.48%(+53.5%)
Jun 2014
-
-246.23%(-121.5%)
Mar 2014
-
1144.93%(-8.7%)
Dec 2013
2673.89%(+591.0%)
1254.11%(+106.0%)
Sep 2013
-
-20.94K%(-1366.3%)
Jun 2013
-
-1428.45%(-244.8%)
Mar 2013
-
-414.30%(-33.5%)
Dec 2012
-544.61%(-284.0%)
-310.44%(-34.7%)
Sep 2012
-
-230.43%(-19.2%)
Jun 2012
-
-193.31%(-21.8%)
Mar 2012
-
-158.72%(-11.4%)
Dec 2011
-141.82%(-217.9%)
-142.52%(-39.9%)
Sep 2011
-
-101.87%(-31.1%)
Jun 2011
-
-77.70%(-30.7%)
Mar 2011
-
-59.43%(-43.5%)
Dec 2010
-44.61%(-120.1%)
-41.41%(-244.2%)
Sep 2010
-
-12.03%(+9.7%)
Jun 2010
-
-13.32%(-4.6%)
Mar 2010
-
-12.74%(+57.2%)
Dec 2009
-20.27%
-29.76%(+43.9%)
DateAnnualQuarterly
Sep 2009
-
-53.02%(-21.5%)
Jun 2009
-
-43.64%(+9.7%)
Mar 2009
-
-48.31%(+5.1%)
Dec 2008
-44.43%(+34.2%)
-50.89%(+28.1%)
Sep 2008
-
-70.73%(+14.4%)
Jun 2008
-
-82.61%(-3.1%)
Mar 2008
-
-80.09%(+3.5%)
Dec 2007
-67.52%(+38.4%)
-83.01%(+36.8%)
Sep 2007
-
-131.39%(+24.6%)
Jun 2007
-
-174.26%(-27.3%)
Mar 2007
-
-136.87%(-30.1%)
Dec 2006
-109.60%(-84.3%)
-105.24%(-13.9%)
Sep 2006
-
-92.36%(-30.4%)
Jun 2006
-
-70.83%(-16.7%)
Mar 2006
-
-60.69%(+2.5%)
Dec 2005
-59.47%(+18.6%)
-62.27%(+4.5%)
Sep 2005
-
-65.20%(-13.7%)
Jun 2005
-
-57.32%(-4.2%)
Mar 2005
-
-55.03%(+8.6%)
Dec 2004
-73.05%(-97.2%)
-60.19%(-11.4%)
Sep 2004
-
-54.04%(-10.9%)
Jun 2004
-
-48.74%(-10.5%)
Mar 2004
-
-44.12%(-18.8%)
Dec 2003
-37.04%(-6.0%)
-37.15%(-13.0%)
Sep 2003
-
-32.87%(-8.2%)
Jun 2003
-
-30.37%(+6.1%)
Mar 2003
-
-32.35%(+9.3%)
Dec 2002
-34.93%(-314.4%)
-35.66%(+3.6%)
Sep 2002
-
-37.01%(-33.8%)
Jun 2002
-
-27.66%(-74.7%)
Mar 2002
-
-15.83%(-91.4%)
Dec 2001
-8.43%(-2.1%)
-8.27%(-182.3%)
Sep 2001
-
-2.93%(+51.1%)
Jun 2001
-
-5.99%(+40.8%)
Mar 2001
-
-10.11%(-95.9%)
Dec 2000
-8.26%(+22.7%)
-5.16%(-109.8%)
Sep 2000
-
-2.46%(+36.3%)
Jun 2000
-
-3.86%(-216.4%)
Mar 2000
-
-1.22%(+90.8%)
Dec 1999
-10.69%(+40.8%)
-13.23%(+47.3%)
Sep 1999
-
-25.11%(-318.5%)
Jun 1999
-
-6.00%(+66.0%)
Mar 1999
-
-17.64%(+14.2%)
Dec 1998
-18.07%(+48.4%)
-20.57%(+21.2%)
Sep 1998
-
-26.12%(+42.0%)
Jun 1998
-
-45.06%(-19.5%)
Mar 1998
-
-37.72%(-8.0%)
Dec 1997
-35.00%(-6.2%)
-34.91%(-14.2%)
Sep 1997
-
-30.57%(+6.4%)
Jun 1997
-
-32.67%(-0.6%)
Mar 1997
-
-32.48%(+2.3%)
Dec 1996
-32.95%(+56.8%)
-33.25%(+19.9%)
Sep 1996
-
-41.53%(+13.0%)
Jun 1996
-
-47.75%(+17.2%)
Mar 1996
-
-57.66%(+20.1%)
Dec 1995
-76.23%(-22.8%)
-72.15%(-7.9%)
Sep 1995
-
-66.88%(-2.4%)
Jun 1995
-
-65.29%(+4.8%)
Mar 1995
-
-68.56%(-27.9%)
Dec 1994
-62.08%
-53.59%(-41.1%)
Sep 1994
-
-37.97%(-48.1%)
Jun 1994
-
-25.64%(-133.9%)
Mar 1994
-
-10.96%

FAQ

  • What is BioCryst Pharmaceuticals, Inc. annual return on equity?
  • What is the all-time high annual ROE for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is BioCryst Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of BCRX is 18.68%

What is the all-time high annual ROE for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high annual return on equity is 2673.89%

What is BioCryst Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, BCRX annual return on equity has changed by -31.05% (-62.44%)

What is BioCryst Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of BCRX is 7.86%

What is the all-time high quarterly ROE for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high quarterly return on equity is 1254.11%

What is BioCryst Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, BCRX quarterly return on equity has changed by -24.24% (-75.51%)
On this page